Skip to main content
Official Logo of Columbia Business School
Academics
  • Visit Academics
  • Degree Programs
  • Admissions
  • Tuition & Financial Aid
  • Campus Life
  • Career Management
Faculty & Research
  • Visit Faculty & Research
  • Academic Divisions
  • Search the Directory
  • Research
  • Faculty Resources
  • Teaching Excellence
Executive Education
  • Visit Executive Education
  • For Organizations
  • For Individuals
  • Program Finder
  • Online Programs
  • Certificates
About Us
  • Visit About Us
  • CBS Directory
  • Events Calendar
  • Leadership
  • Our History
  • The CBS Experience
  • Newsroom
Alumni
  • Visit Alumni
  • Update Your Information
  • Lifetime Network
  • Alumni Benefits
  • Alumni Career Management
  • Women's Circle
  • Alumni Clubs
Insights
  • Visit Insights
  • Digital Future
  • Climate
  • Business & Society
  • Entrepreneurship
  • 21st Century Finance
  • Magazine

Breadcrumb

  1. Directory
  2. Faculty
  3. Frank Lichtenberg

Frank Lichtenberg

Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business
Economics Division
Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business
Healthcare and Pharmaceutical Management Program
Photo of Professor Frank R. Lichtenberg
Areas of Expertise
Healthcare, Macroeconomics, Microeconomics
Contact
Office: 522 Kravis
E-mail: [email protected]
Links
Personal Website
Curriculum Vitae

Frank R. Lichtenberg is Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business Economics at the Columbia University Graduate School of Business; a Research Associate of the National Bureau of Economic Research; and a member of the CESifo Research Network. He received a BA with Honors in History from the University of Chicago and an MA and PhD in Economics from the University of Pennsylvania.

Mr. Lichtenberg previously taught at Harvard University, the University of Pennsylvania, and Ecole Polytechnique. He has served as an expert for the Federal Trade Commission, the U.S. Dept. of Justice, and state Attorneys General, and has testified before Congress. He has worked for several U.S. government agencies, including the Department of Justice, the Congressional Budget Office, and the Census Bureau, and been a visiting scholar at the Wissenschaftszentrum Berlin, the University of Munich, and elsewhere.

Some of Professor Lichtenberg’s research has examined how the introduction of new technology arising from research and development affects the productivity of companies, industries and nations. He has performed studies of the impact of pharmaceutical innovation on longevity, the effect of computers on productivity in business and government organizations, and the consequences of takeovers and leveraged buyouts for efficiency and employment. His articles have been published in numerous scholarly journals and in the popular press. His book Corporate Takeovers and Productivity has been published by MIT Press.

He was awarded the 1998 Schumpeter Prize for his paper, Pharmaceutical Innovation as a Process of Creative Destruction; the 2003 Milken Institute Award for Distinguished Economic Research for the paper, Pharmaceutical Knowledge-Capital Accumulation and Longevity; and Research!America’s 2010 Garfield Economic Impact Award for the paper, The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004.

He has been awarded research fellowships, grants, and contracts by the National Science Foundation, the World Health Organization, the National Institute of Standards and Technology, Merck and Co., the Fulbright Commission, the Brookings Institution, the Alfred P. Sloan Foundation, The German Marshall Fund, the American Enterprise Institute, and other organizations. He has served as a consultant to private organizations and government agencies including the Securities Industry Association, Pfizer, Inc., the Community Preservation Corporation, the RAND Corporation, the New York City Water Board, Touche Ross and Co., The Walt Disney Company, McGraw-Hill, and the National Pharmaceutical Council. He is an affiliate of the economics consulting firm Analysis Group.

Education
BA, University of Chicago, 1973; MA, University of Pennsylvania, 1976; PhD, 1982
Joined CBS
1983

All Activities

  • Research
  • Teaching
  • Awards and Honors
  • Press
  • CaseWorks
  • Journal articles
  • Working papers
  • Articles
  • Books
  • Chapters
Journal Article
Lichtenberg, Frank
. “The long-run impact of new medical ideas on cancer survival and mortality.”
Economics of Innovation and New Technology
vol.
28
, no.
7
(October 03, 2019):
722
-
740
.
Explore Further about The long-run impact of new medical ideas on cancer survival and mortality
Download PDF on The long-run impact of new medical ideas on cancer survival and mortality
Journal Article
Lichtenberg, Frank
. “How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013.”
International Health
vol.
11
, no.
5
(September 02, 2019):
403
-
416
.
Explore Further about How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013
Download PDF on How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013
Journal Article
Lichtenberg, Frank
. “The impact of access to prescription drugs on disability in eleven European countries.”
Disability and Health Journal
vol.
12
, no.
3
(July 01, 2019):
375
-
386
.
Explore Further about The impact of access to prescription drugs on disability in eleven European countries
Download PDF on The impact of access to prescription drugs on disability in eleven European countries
Journal Article
Lichtenberg, Frank
. “The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis.”
Forum for Health Economics & Policy
vol.
21
, no.
2
(April 24, 2019).
Explore Further about The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis
Download PDF on The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis
Journal Article
Lichtenberg, Frank
. “The Physician-Patient Relationship in the Age of Precision Medicine.”
Genetics in Medicine
vol.
21
, no.
4
(April 01, 2019):
813
-
815
.
Explore Further about The Physician-Patient Relationship in the Age of Precision Medicine
Download PDF on The Physician-Patient Relationship in the Age of Precision Medicine
Journal Article
Lichtenberg, Frank
. “The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the U.S., 1999- 2013.”
The American Economist
vol.
63
, no.
2
(October 01, 2018):
147
-
165
.
Explore Further about The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the U.S., 1999- 2013
Download PDF on The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the U.S., 1999- 2013
Journal Article
Lichtenberg, Frank
. “The impact of new drug launches on longevity growth in 9 Middle Eastern and African countries, 2007-2015.”
Review of Middle East Economics and Finance
vol.
14
, no.
3
(September 21, 2018).
Explore Further about The impact of new drug launches on longevity growth in 9 Middle Eastern and African countries, 2007-2015
Download PDF on The impact of new drug launches on longevity growth in 9 Middle Eastern and African countries, 2007-2015
Journal Article
Lichtenberg, Frank
. “The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.”
Journal of Demographic Economics
vol.
84
, no.
3
(August 01, 2018):
309
-
354
.
Explore Further about The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries
Download PDF on The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on cancer mortality in Russia, 2001-2011.”
Journal of Pharmaceutical Health Services Research
vol.
9
, no.
2
(June 01, 2018):
79
-
89
.
Explore Further about The impact of pharmaceutical innovation on cancer mortality in Russia, 2001-2011
Download PDF on The impact of pharmaceutical innovation on cancer mortality in Russia, 2001-2011
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013.”
Latin American Economic Review
vol.
26
, no.
1
(October 17, 2017).
Explore Further about The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
Download PDF on The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
Journal Article
Lichtenberg, Frank
. “The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia.”
Economic Record
vol.
93
, no.
302
(September 01, 2017):
353
-
378
.
Explore Further about The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia
Download PDF on The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia
Journal Article
Lichtenberg, Frank, Mehtap Tatar, and Zafer Caliskan
. “The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination.”
Health Policy and Technology
vol.
6
, no.
2
(June 01, 2017):
226
-
333
.
Explore Further about The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination
Download PDF on The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012.”
The European Journal of Health Economics
vol.
17
, no.
7
(September 07, 2016):
833
-
854
.
Explore Further about The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on cancer mortality in Belgium, 2004-2012.”
Forum for Health Economics and Policy
vol.
20
, no.
1
(September 01, 2016).
Explore Further about The impact of pharmaceutical innovation on cancer mortality in Belgium, 2004-2012
Download PDF on The impact of pharmaceutical innovation on cancer mortality in Belgium, 2004-2012
Journal Article
Lichtenberg, Frank
. “The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011.”
International Journal of Health Economics and Management
vol.
15
, no.
3
(September 01, 2015):
339
-
355
.
Explore Further about The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011
Download PDF on The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011
Journal Article
Lichtenberg, Frank
. “Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995-2010.”
International Journal of the Economics of Business
vol.
22
, no.
2
(June 26, 2015):
277
-
299
.
Explore Further about Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995-2010
Download PDF on Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995-2010
Journal Article
Hostenkamp, Gisela and Frank Lichtenberg
. “The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.”
Social Science & Medicine
vol.
130
, (April 01, 2015):
162
-
171
.
Explore Further about The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence
Download PDF on The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010.”
Applied Health Economics and Health Policy
vol.
13
, no.
2
(April 01, 2015):
207
-
222
.
Explore Further about The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010
Download PDF on The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010
Journal Article
Lichtenberg, Frank
. “The impact of biomedical innovation on longevity and health.”
Nordic Journal of Health Economics
vol.
5
, no.
1
(March 09, 2015):
45
-
57
.
Explore Further about The impact of biomedical innovation on longevity and health
Download PDF on The impact of biomedical innovation on longevity and health
Journal Article
Lichtenberg, Frank
. “The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012.”
Nordic Journal of Health Economics
vol.
5
, no.
1
(March 01, 2015):
23
-
44
.
Explore Further about The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012
Download PDF on The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on disability days and the use of medical services in the United States, 1997-2010.”
Journal of Human Capital
vol.
8
, no.
4
(December 01, 2014):
432
-
480
.
Explore Further about The impact of pharmaceutical innovation on disability days and the use of medical services in the United States, 1997-2010
Download PDF on The impact of pharmaceutical innovation on disability days and the use of medical services in the United States, 1997-2010
Journal Article
Lichtenberg, Frank, Mehtap Tatar, and Zafer Caliskan
. “The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010.”
Health Policy
vol.
117
, no.
3
(September 21, 2014):
361
-
373
.
Explore Further about The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010
Download PDF on The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010
Journal Article
Lichtenberg, Frank
. “Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009.”
Health Policy and Technology
vol.
3
, (March 01, 2014):
36
-
58
.
Explore Further about Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
Journal Article
Lichtenberg, Frank
. “Has Medical Innovation Reduced Cancer Mortality?”
CESifo Economic Studies
vol.
60
, no.
1
(March 01, 2014):
135
-
177
.
Explore Further about Has Medical Innovation Reduced Cancer Mortality?
Download PDF on Has Medical Innovation Reduced Cancer Mortality?
Journal Article
Lichtenberg, Frank
. “The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009.”
Economics & Human Biology
vol.
13
, (March 01, 2014):
107
-
127
.
Explore Further about The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009
Download PDF on The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009
Journal Article
Lichtenberg, Frank and Billie Pettersson
. “The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data.”
Economics of Innovation and New Technology
vol.
23
, no.
3
(September 02, 2013):
239
-
273
.
Explore Further about The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data
Download PDF on The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data
Journal Article
Lichtenberg, Frank
. “The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files.”
Forum for Health Economics and Policy
vol.
16
, no.
1
(January 01, 2013):
1
-
33
.
Explore Further about The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
Download PDF on The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
Journal Article
Lichtenberg, Frank
. “The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007.”
PharmacoEconomics
vol.
30
, (March 01, 2012):
197
-
211
.
Explore Further about The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007
Download PDF on The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007
Journal Article
Lichtenberg, Frank
. “Has Pharmaceutical Innovation Reduced Social Security Disability Growth?”
International Journal of the Economics of Business
vol.
18
, (July 01, 2011):
293
-
316
.
Explore Further about Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
Download PDF on Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
Journal Article
Lichtenberg, Frank
. “Despite steep costs, payments for new cancer drugs make economic sense.”
Nature Medicine
vol.
17
, (March 07, 2011):
244
.
Explore Further about Despite steep costs, payments for new cancer drugs make economic sense
Download PDF on Despite steep costs, payments for new cancer drugs make economic sense
Journal Article
Lichtenberg, Frank
. “The quality of medical care, behavioral risk factors, and longevity growth.”
International Journal of Health Care Finance and Economics
vol.
11
, (March 01, 2011):
1
-
34
.
Explore Further about The quality of medical care, behavioral risk factors, and longevity growth
Journal Article
Lichtenberg, Frank and Bhaven Sampat
. “What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?”
Health Affairs
vol.
30
, (February 15, 2011):
332
-
339
.
Explore Further about What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?
Journal Article
Lichtenberg, Frank
. “Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia.”
Forum for Health Economics & Policy
vol.
13
, (May 21, 2010):
Article 11
.
Explore Further about Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
Download PDF on Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
Journal Article
Lichtenberg, Frank
. “Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos.”
Social Science and Medicine
vol.
70
, (February 12, 2010):
969
-
971
.
Explore Further about Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos
Journal Article
Lichtenberg, Frank
. “Pharmaceutical Price Discrimination and Social Welfare.”
Capitalism and Society
vol.
5
, (January 01, 2010):
Article 2
.
Explore Further about Pharmaceutical Price Discrimination and Social Welfare
Download PDF on Pharmaceutical Price Discrimination and Social Welfare
Journal Article
Lichtenberg, Frank
. “The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program.”
Advances in health economics and health services research
vol.
22
, (January 01, 2010):
273
-
292
.
Explore Further about The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program
Download PDF on The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program
Journal Article
Lichtenberg, Frank
. “Availability of New Drugs and Americans' Ability to Work.”
Journal of Occupational and Environmental Medicine
(April 01, 2005).
Explore Further about Availability of New Drugs and Americans' Ability to Work
Download PDF on Availability of New Drugs and Americans' Ability to Work
Journal Article
Lichtenberg, Frank
. “The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001.”
International Journal of Health Care Finance and Economics
vol.
5
, (January 01, 2005):
47
-
73
.
Explore Further about The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001
Download PDF on The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001
Journal Article
Lichtenberg, Frank
. “The Effects of Medicare on Health Care Utilization and Outcomes.”
Frontiers in Health Policy Research
vol.
5
, (January 01, 2002):
27
-
52
.
Explore Further about The Effects of Medicare on Health Care Utilization and Outcomes
Download PDF on The Effects of Medicare on Health Care Utilization and Outcomes
Journal Article
Lichtenberg, Frank
. “Do (More and Better) Drugs Keep People Out of Hospitals?”
American Economic Review
vol.
86
, (May 01, 1996):
384
-
88
.
Explore Further about Do (More and Better) Drugs Keep People Out of Hospitals?
Download PDF on Do (More and Better) Drugs Keep People Out of Hospitals?
Journal Article
Lichtenberg, Frank
. “The Private R and D Investment Response to Federal Design and Technical Competitions.”
American Economic Review
vol.
78
, (June 01, 1988):
550
-
59
.
Explore Further about The Private R and D Investment Response to Federal Design and Technical Competitions
Download PDF on The Private R and D Investment Response to Federal Design and Technical Competitions
Journal Article
Bartel, Ann and Frank Lichtenberg
. “The Comparative Advantage of Educated Workers in Implementing New Technology.”
Review of Economics and Statistics
vol.
69
, (February 01, 1987):
1
-
11
.
Explore Further about The Comparative Advantage of Educated Workers in Implementing New Technology
Download PDF on The Comparative Advantage of Educated Workers in Implementing New Technology
Working Paper
Lichtenberg, Frank
. The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data. October 01, 2013.
Explore Further about The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
Download PDF on The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
Working Paper
Lichtenberg, Frank
. The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007. January 10, 2011.
Explore Further about The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007
Download PDF on The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007
Working Paper
Lichtenberg, Frank
. Has medical innovation reduced cancer mortality? November 30, 2010.
Explore Further about Has medical innovation reduced cancer mortality?
Download PDF on Has medical innovation reduced cancer mortality?
Working Paper
Lichtenberg, Frank
. Is Home Health Care a Substitute for Hospital Care? October 28, 2010.
Explore Further about Is Home Health Care a Substitute for Hospital Care?
Download PDF on Is Home Health Care a Substitute for Hospital Care?
Working Paper
Lichtenberg, Frank
. The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data. May 27, 2010.
Explore Further about The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data
Download PDF on The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data
Working Paper
Lichtenberg, Frank
. The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth. June 01, 2009.
Explore Further about The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
Download PDF on The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
Working Paper
Lichtenberg, Frank and Suchin Virabhak
. Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health'. January 01, 2005.
Explore Further about Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health'
Working Paper
Lichtenberg, Frank
. The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output. January 01, 2005.
Explore Further about The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output
Working Paper
Lichtenberg, Frank
. The Expanding Pharmaceutical Arsenal in the War on Cancer. January 01, 2005.
Explore Further about The Expanding Pharmaceutical Arsenal in the War on Cancer
Download PDF on The Expanding Pharmaceutical Arsenal in the War on Cancer
Working Paper
Lichtenberg, Frank
. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry. January 01, 2005.
Explore Further about The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry
Working Paper
Lichtenberg, Frank
. Benefits and Costs of Newer Drugs: An Update. January 01, 2005.
Explore Further about Benefits and Costs of Newer Drugs: An Update
Working Paper
Lleras-Muney, Adriana and Frank Lichtenberg
. The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs? January 01, 2005.
Explore Further about The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs?
Working Paper
Lichtenberg, Frank
. Sources of U.S. Longevity Increase, 1960-1997. January 01, 2005.
Explore Further about Sources of U.S. Longevity Increase, 1960-1997
Working Paper
Lichtenberg, Frank
. The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001. January 01, 2005.
Explore Further about The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001
Working Paper
Lichtenberg, Frank
. The Effect of New Drugs on Mortality from Rare Diseases and HIV. May 01, 2002.
Explore Further about The Effect of New Drugs on Mortality from Rare Diseases and HIV
Working Paper
Lichtenberg, Frank
. The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey. January 01, 2001.
Explore Further about The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
Working Paper
Lichtenberg, Frank
. Pharmaceutical Innovation, Mortality Reduction, and Economic Growth. May 01, 1998.
Explore Further about Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
Working Paper
Lichtenberg, Frank
. The Allocation of Publicly-Funded Biomedical Research. January 01, 1998.
Explore Further about The Allocation of Publicly-Funded Biomedical Research
Working Paper
Lichtenberg, Frank
. The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality. January 01, 1996.
Explore Further about The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality
Newspaper/Magazine Article
Lichtenberg, Frank
. “Importation and Innovation.”
Chazen Web Journal of International Business
. January 01, 2005.
Explore Further about Importation and Innovation
Download PDF on Importation and Innovation
Newspaper/Magazine Article
Lichtenberg, Frank
. “Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries.”
Chazen Web Journal of International Business
. January 01, 2005.
Explore Further about Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries
Download PDF on Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries
Book
Lichtenberg, Frank
. Corporate Takeovers and Productivity. 
Cambridge, Mass.
:
MIT Press
, 1992.
Explore Further about Corporate Takeovers and Productivity
Chapter
Lichtenberg, Frank and Rebecca Pulk
. “The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy following a Major Cardiovascular Event: Evidence from Geisinger.” In
Economic Dimensions of Personalized and Precision Medicine
, edited by
Ernst Berndt, Dana Goldman, and John Rowe
,
273
-
304
.
Chicago
:
The University of Chicago Press
, 2019.
Explore Further about The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy following a Major Cardiovascular Event: Evidence from Geisinger
Download PDF on The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy following a Major Cardiovascular Event: Evidence from Geisinger
Chapter
Lichtenberg, Frank
. “The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data in Measuring and Modeling Health Care Costs.” In
Measuring and Modeling Health Care Costs
, edited by
Ana Aizcorbe, Colin Baker, Ernst Berndt, and David Cutler
,
475
-
504
.
Chicago
:
The University of Chicago Press
, 2018.
Explore Further about The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data in Measuring and Modeling Health Care Costs
Download PDF on The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data in Measuring and Modeling Health Care Costs
Chapter
Lichtenberg, Frank
. “Pharmaceutical Knowledge-Capital Accumulation and Longevity.” In
Measuring Capital in the New Economy
, edited by
Carol Corrado, John Haltiwanger, and Daniel Sichel
,
Chicago
:
University of Chicago Press
, 2005.
Explore Further about Pharmaceutical Knowledge-Capital Accumulation and Longevity
Download PDF on Pharmaceutical Knowledge-Capital Accumulation and Longevity
  • Courses
  • Case Studies
Course
B6200: Managerial Economics
View Course on Managerial Economics
Course
B5200: Managerial Economics
View Course on Managerial Economics
Course
B8221: Economics of Healthcare and Pharmaceuticals
View Course on Economics of Healthcare and Pharmaceuticals
  • Awards & Honors
  • In the Media
  • Articles
In the Media

Americans Pay a Lot for Drugs Because They’re Worth It

Washington Post
In the Media

Why Ozempic and Other Weight-Loss Drugs Could Drive More Gym Sign-Ups This January

The Messenger
In the Media

Delta Air Lines' Raising Insurance Rates for Unvaccinated Makes Dense - and It's a Scary Idea

The Los Angeles Times
In the Media

Creating a Covid-19 Vaccine Is Only the First Step. Reaching the World Is the Next.

NBC News
In the Media

How Much Could Pfizer Make from a COVID-19 Vaccine?

Marketplace
In the Media

Why You Should Take Coronavirus Vaccine News with a Grain of Salt

Salon
In the Media

Wave of 'Vaccine Nationalism' Hinders Global Efforts to Halt Coronavirus

NBC News
In the Media

Democrats Tout Federal Patent Take-Backs for Lowering Drug Costs

Bloomberg News
Article

Why the High Cost of New Drugs Might Be a Bargain

Read More about Why the High Cost of New Drugs Might Be a Bargain
Article

Newer Drugs Increase Medication Adherence, Improving Health Outcomes and Decreasing Health Care Costs

Read More about Newer Drugs Increase Medication Adherence, Improving Health Outcomes and Decreasing Health Care Costs
Article

Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years after Launch

Read More about Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years after Launch
Article

The Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation

Read More about The Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation
Article

Professor Frank Lichtenberg Receives 2003 Milken Institute Award for Distinguished Economic Research

Read More about Professor Frank Lichtenberg Receives 2003 Milken Institute Award for Distinguished Economic Research
  • CaseWorks
Case ID
160311

Can Health Technology Assessment Help Control Drug Costs?

How does a health technology assessment (HTA) tool help to guide the pricing of pharmaceutical products?

View Case on Can Health Technology Assessment Help Control Drug Costs?

External CSS

Official Logo of Columbia Business School

Columbia University in the City of New York
665 West 130th Street, New York, NY 10027
Tel. 212-854-1100

Maps and Directions
    • Centers & Programs
    • Current Students
    • Corporate
    • Directory
    • Support Us
    • Recruiters & Partners
    • Faculty & Staff
    • Newsroom
    • Careers
    • Contact Us
    • Accessibility
    • Privacy & Policy Statements
Back to Top Upward arrow
TOP

© Columbia University

  • X
  • Instagram
  • Facebook
  • YouTube
  • LinkedIn